[1] Vejakama P, Ingsathit A, Attia J, et al.Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study[J].Medicine (Baltimore),2015,94(4):e475. [2] Zhang L, Wang F, Wang L, et al.Prevalence of kidney disease in China: a cross sectional survey[J].Lancet, 2012,379(9818):815-822. [3] 王俊琪.社区慢性肾病高危人群中医药综合干预研究[D].上海:复旦大学,2014. [4] 张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. [5] 吴克娟,罗国慧,陈兰.慢性肾脏病社区早期筛查管理的重要性[J].中国慢性病预防与控制,2018,26(8):632-634. [6] National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease: evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39 (2 Suppl 1):S1-266. [7] 唐刚,周志明,张镕,等.上海市松江区佘山镇常住人口肾功能损伤情况及其相关因素[J].上海预防医学,2018,30(5):358-362. [8] 王善志,朱永俊,唐文庄,等.中国成人及老年人群慢性肾脏病患病率meta分析[J].中国老年学杂志,2017,37(21):5384-5388. [9] 卓琳,蔡卿卿,刘丁阳,等.慢性肾脏病的患病率及危险因素荟萃分析[J].中国老年学杂志,2018,38(9):2135-2138. [10] 李增芳,杨芬芳,蔡菊芳,等.杭州市5 310例健康体检人群慢性肾脏病的患病情况及危险因素分析[J].实用预防医学,2016,23(8):969-972. [11] Weiner DE, Tighiouart H, Elsayed EF, et al.Uric acid and incident kidney disease in the community[J].J Am Soc Nephrol,2008,19(6):1204-1211. [12] Liu DW, Wan J, Liu ZS, et al.Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly Chinese population[J].Chin Med J (Engl),2013,126(7):1207-1212. [13] 鲁盛康,蒋春红,张亮.湖北省城乡居民门诊就医选择影响因素分析[J].中华医院管理杂志,2018,34(1):76-79. [14] 孙叶海,李顺东,聂胡,等.群组管理对社区高血压肾损害患者的作用[J].实用预防医学,2018,25(3):347-349.
2020, Vol. 27 
